Neutralizing ceramide: a major breakthrough or yet another marginal target for the treatment of acute lung injury?

Pediatr Res. 2005 Mar;57(3):319-21. doi: 10.1203/01.PDR.0000153948.44951.5B. Epub 2005 Jan 5.
No abstract available

Publication types

  • News

MeSH terms

  • Adrenergic Uptake Inhibitors / therapeutic use
  • Animals
  • Bridged-Ring Compounds / therapeutic use*
  • Ceramides / antagonists & inhibitors*
  • Ceramides / metabolism
  • Edema / prevention & control
  • Humans
  • Imipramine / therapeutic use
  • Mice
  • Norbornanes
  • Phosphodiesterase Inhibitors / therapeutic use*
  • Respiratory Distress Syndrome / drug therapy*
  • Respiratory Distress Syndrome / metabolism
  • Sphingomyelin Phosphodiesterase / antagonists & inhibitors
  • Thiocarbamates
  • Thiones / therapeutic use*

Substances

  • Adrenergic Uptake Inhibitors
  • Bridged-Ring Compounds
  • Ceramides
  • Norbornanes
  • Phosphodiesterase Inhibitors
  • Thiocarbamates
  • Thiones
  • tricyclodecane-9-yl-xanthogenate
  • Sphingomyelin Phosphodiesterase
  • Imipramine